Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NIRTRAKS - (NIRxcell TRial for a Post mArKet Study)

NCT02455804 is registered in ClinicalTrials.gov with Medinol Ltd. as lead sponsor.

NCT NCT02455804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02455804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NIRTRAKS - (NIRxcell TRial for a Post mArKet Study)
Lead sponsor
Medinol Ltd.
Phase
Not applicable
Overall status
Completed
Start date
January 8, 2016
Completion date
January 14, 2020
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

de novo stenotic lesions in native coronary arteries